(2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C22H25N7O4 — CID 24832767

IUPAC(2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
SMILESOC[C@H]1O[C@@H](n2cnc3c(NCCc4cn(Cc5ccccc5)cn4)ncnc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C22H25N7O4/c30-10-16-18(31)19(32)22(33-16)29-13-27-17-20(24-11-25-21(17)29)23-7-6-15-9-28(12-26-15)8-14-4-2-1-3-5-14/h1-5,9,11-13,16,18-19,22,30-32H,6-8,10H2,(H,23,24,25)/t16-,18-,19-,22-/m1/s1
InChIKeyAJIKUHNMVHWNPK-WGQQHEPDSA-N
MW451.49 g/mol
LogP0.34
Rot. Bonds8

About (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

(2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol (PubChem CID 24832767) has the molecular formula C22H25N7O4 and a molecular weight of 451.49 g/mol. Its IUPAC name is (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol.

Molecular Properties

Compound Name(2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
PubChem CID24832767
Molecular FormulaC22H25N7O4
Molecular Weight451.49 g/mol
Exact Mass451.20
IUPAC Name(2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
SMILESOC[C@H]1O[C@@H](n2cnc3c(NCCc4cn(Cc5ccccc5)cn4)ncnc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C22H25N7O4/c30-10-16-18(31)19(32)22(33-16)29-13-27-17-20(24-11-25-21(17)29)23-7-6-15-9-28(12-26-15)8-14-4-2-1-3-5-14/h1-5,9,11-13,16,18-19,22,30-32H,6-8,10H2,(H,23,24,25)/t16-,18-,19-,22-/m1/s1
InChIKeyAJIKUHNMVHWNPK-WGQQHEPDSA-N
XLogP0.34
TPSA143.37 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds8
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500451.49
LogP ≤ 50.34
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol?
The IUPAC name of (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol (CID 24832767) is (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol.
What is the SMILES notation for (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol?
The canonical SMILES for (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol is OC[C@H]1O[C@@H](n2cnc3c(NCCc4cn(Cc5ccccc5)cn4)ncnc32)[C@H](O)[C@@H]1O.
What is the InChIKey of (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol?
The InChIKey is AJIKUHNMVHWNPK-WGQQHEPDSA-N. The full InChI is InChI=1S/C22H25N7O4/c30-10-16-18(31)19(32)22(33-16)29-13-27-17-20(24-11-25-21(17)29)23-7-6-15-9-28(12-26-15)8-14-4-2-1-3-5-14/h1-5,9,11-13,16,18-19,22,30-32H,6-8,10H2,(H,23,24,25)/t16-,18-,19-,22-/m1/s1.
What are the key properties of (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol?
(2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol has a molecular weight of 451.49 g/mol, XLogP of 0.34, 8 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R,4S,5R)-2-[6-[2-(1-benzylimidazol-4-yl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol is sourced from PubChem (CID 24832767), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).